Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • HOW I TREAT FEBRILE NEUTROPENIA

    Marcio Nucci
    e2021025
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.025
    7241
    PDF: 4100
    HTML: 677
  • TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS

    Lanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, Federico Giannoni
    e2013072
    2013-11-19
    https://doi.org/10.4084/mjhid.2013.072
    3196
    PDF: 1073
    HTML: 3225
  • MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

    Alfredo Marzano
    e2009025
    https://doi.org/10.4084/mjhid.2009.025
    907
    PDF: 513
    HTML: 1317
  • ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Murat Akova
    e2017002
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.002
    4200
    PDF: 1320
    HTML: 2122
    Table 1: 232
  • HEPATITIS C VIRUS INFECTION AND LYMPHOMA

    Emmanuel Bachy, Caroline Besson, Felipe Suarez, Olivier Hermine
    e2010004
    2010-03-25
    https://doi.org/10.4084/mjhid.2010.004
    1124
    PDF: 656
    HTML: 7883
  • ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE

    Lijie Ma, Ling Chen
    e2026034
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.034
    263
    PDF: 382
    Suppl. Files: 74
    HTML: 163
  • PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Isidro Jarque, Miguel Salavert, Javier Pemán
    e2016035
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.035
    3843
    PDF: 1333
    HTML: 3937
    Untitled: 279
    Untitled: 312
  • Elevated endogenous alveolar carbon monoxide concentration in patients with transfusion-dependent thalassemia and its relation to ineffective erythropoiesis

    Yanni Xie
    e2025047
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.047
    648
    PDF: 494
    HTML: 56
  • IMPORTANCE OF SOURCE CONTROL IN THE SUBGROUP OF INTRA-ABDOMINAL INFECTIONS FOR SEPTIC SHOCK PATIENTS: ANALYSIS OF 390 CASES

    Uğur Önal, Deniz Akyol, Olcay Buse Kenanoğlu, Merve Mert, Dilşah Başkol, Seichan Chousein Memetali, Gamze Şanlıdağ, Cansu Bulut, Arda Kaya, Ayşe Uyan Önal, Nazlıhan Yalçın, Günel Guliyeva, Şükrü Dirik, Oğuzhan Acet, Damla Akdağ, Melike Demir, Osman Bozbıyık, Berk Göktepe, Tufan Gümüş, İlkin Çankayalı, Kubilay Demirağ, Mehmet Uyar, Hilal Sipahi, Hüseyin Aytaç Erdem, Meltem Işıkgöz Taşbakan, Bilgin Arda, Şöhret Aydemir, Sercan Ulusoy, Oğuz Reşat Sipahi
    e2024051
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.051
    1198
    PDF: 1191
    HTML: 191
  • Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF

    Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun
    e2022025
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.025
    1881
    PDF: 631
    HTML: 364
  • TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA

    Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Gianantonio Rosti
    e2014005
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.005
    3497
    PDF: 1564
    HTML: 4085
  • EVALUATION OF ORAL DOXYCYCLINE, AZITHROMYCIN, OR SEQUENTIAL DOXYCYCLINE-AZITHROMYCIN TREATMENT FOR SCRUB TYPHUS-

    Hanchen Liu, Weizhen Wang, Yuqing Dong
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.020
    825
    PDF: 639
    HTML: 188
  • CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

    Vincenzo De Sanctis
    e2020006
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.006
    4420
    PDF: 1591
    HTML: 478
  • Allogeneic Hematopoietic Stem Cell Transplantation in Hemophagocytic LymphohistiocytosisTwo Sides of the Locket: Trigger or Cure?

    Ahmet Alparslan Ceran, Irem Eser Sarı, Tugce Sevval Yildiz, Ahmet Seyhanli, Zeynep Arzu Yegin, Zubeyde Nur Ozkurt, Abdullah Munci Yagci
    e2026073
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.073
    119
    PDF: 83
    Html: 18
  • ECONOMIC EVALUATION OF CHELATION REGIMENS FOR ?--THALASSEMIA MAJOR: A SYSTEMATIC REVIEW

    Jialian Li
    e2019036
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.036
    2158
    PDF: 1514
    HTML: 257
  • GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Laura Breda, Roberto Gambari, Stefano Rivella
    e2009008
    2009-11-16
    1391
    PDF: 452
    HTML: 3148
  • The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.

    Sumeyye Kazancioglu, Ebru Ayöztürk, Seval Izdes, Rahmet Guner
    e2026050
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.050
    241
    PDF: 224
    HTML: 61
  • ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

    Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca
    e2020075
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.075
    1732
    PDF: 1501
    HTML: 631
  • HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

    Armando Tripodi
    e2024027
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.027
    1113
    PDF: 1435
    HTML: 168
  • DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE

    Zeno Bisoffi, Federico Gobbi, Dora Buonfrate, Jef Van den Ende
    e2012036
    2012-05-09
    https://doi.org/10.4084/mjhid.2012.036
    3743
    PDF: 1178
    HTML: 23381
  • ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica
    e2010026
    2010-08-31
    https://doi.org/10.4084/mjhid.2010.026
    1498
    PDF: 862
    HTML: 1035
  • THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis

    Kun Yang, Jian Xiao
    e2024001
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.001
    1528
    PDF: 1494
    PDF: 1074
    HTML: 234
  • LEVOFLOXACIN PROPHYLAXIS VERSUS NO PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA DURING POST-INDUCTION APLASIA: A SINGLE CENTER STUDY

    Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio
    e2023022
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.022
    1843
    PDF: 1159
    HTML: 427
  • HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

    Anna Maria Testi
    e2022038
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.038
    1376
    PDF: 907
    HTML: 270
  • IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

    Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi
    e2017010
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.010
    3556
    PDF: 1355
    HTML: 2380
    Fi.1 Gritti.Rambaldi: 254
  • PROPHYLACTIC ADMINISTRATION OF DOXYCYCLINE REDUCES CENTRAL VENOUS CATHETER INFECTIONS IN PATIENTS UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION

    Mohamed Kharfan-Dabaja, Mohamed Baydoun, Zaher Otrock, Samar Okaily, Rita Nehme, Racha Abu-Chahine, Ali Hamdan, Samar Noureddine, Souha Kanj, Zeina Kanafani, Ali Bazarbachi
    e2013015
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.015
    1631
    PDF: 940
    HTML: 1415
  • SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib

    Matteo Molica
    e2024079
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.079
    1050
    PDF: 564
    HTML: 339
  • RECENT ADVANCES IN THE 5Q- SYNDROME

    Andrea Pellagatti, Jacqueline Boultwood
    e2015037
    2015-05-20
    https://doi.org/10.4084/mjhid.2015.037
    3041
    PDF: 1919
    HTML: 3826
    Pellagatti Fig 1: 262
    Pellagatti Fig. 2: 249
  • OUTCOME OF CANDIDA PARAPSILOSIS COMPLEX INFECTIONS TREATED WITH CASPOFUNGIN IN CHILDREN

    İlker Devrim, Rana İşgüder, Hasan Ağın, Nuri Bayram, Gökhan Ceylan, Yüce Ayhan, Özlem Saraç Sandal, Ferhat Sarı, Ahu Kara, Mine Düzgöl
    e2016042
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.042
    3749
    PDF: 829
    HTML: 879
  • EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA

    Ulrike Binder, Cornelia Lass-Flörl
    e2011016
    2011-03-30
    https://doi.org/10.4084/mjhid.2011.016
    2346
    PDF: 1049
    HTML: 4988
  • PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT

    Lucia De Franceschi
    e2009024
    2009-12-26
    1154
    PDF: 684
    HTML: 11189
  • ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY

    Tao Zhou, Zengfeng Ni, Wenjing Fan, Jing Xu, Jing Qin, Kaiyue Wang, Rui Wang, Yaping Li
    e2026071
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.071
    112
    PDF: 86
    Suppl. Files: 18
    Html: 18
    Html Suppl. Files: 18
  • GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT

    Sotirios Sachanas, Theodoros Vassilakopoulos, Maria Angelopoulou, sotirios Papageorgiou, Emmanouil Spanoudakis, Maria Bouzani, Maria Dimou, Panagiotis Panagiotidis
    e2025014
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.014
    1549
    HTML: 201
    PDF: 921
  • HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PAEDIATRIC PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE SYNDROME

    Yuan Sun
    e2024036
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.036
    1419
    PDF: 1221
    HTML: 197
  • Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation Pidotimod in SARS-CoV-2 vaccination

    Claudio Ucciferri, Antonio Auricchio, Jacopo Vecchiet, Katia Falasca
    e2022023
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.023
    2364
    PDF: 617
    HTML: 285
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3414
    PDF: 1329
    HTML: 2370
  • CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

    Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi
    e2009030
    https://doi.org/10.4084/mjhid.2009.030
    1410
    PDF: 635
    HTML: 4180
  • Neutropenıa Secondary to Sars-Cov2 Vaccınatıon in Post-Hematopoıetıc Stem Cell Transplant (Hsct) Patıents

    LUIS MIGUEL JUAREZ-SALCEDO, Samantha Feijóo, Cristina García, Alejandro Alonso, Beatriz Aguado, Javier Ortiz, Angela Figuera, Rafael de la Cámara
    e2023014
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.014
    1100
    PDF: 1011
    HTML: 392
  • THE CLINICAL SIGNIFICANCE OF THE SPECTRUM OF INTERACTIONS OF THE RARE IVS-II-5 G>C (HBB: C.315+5 G>C) VARIATION WITH OTHER Β-THALASSEMIA MUTATIONS IN SOUTHERN CHINA

    Yali Zhou, Guiping Liao, Xiaolin Yin, Sheng He, Yi Wu, Jian Xiao, Zhili Geng, Qiuying Huang, Ganghui Luo, Kun Yang
    e2022034
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.034
    1564
    PDF: 657
    HTML: 400
  • ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

    Maria L. Delioukina, Stephen J. Forman
    e2010018
    2010-06-30
    https://doi.org/10.4084/mjhid.2010.018
    1329
    PDF: 832
    HTML: 626
  • BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA

    Alzbeta Zavrelova, Jakub Radocha, Pavla Paterova, Pavel Zak, Benjamin Visek, Martin Sima
    e2023001
    2022-12-31
    https://doi.org/10.4084/MJHID.2023.001
    1411
    PDF: 1177
    HTML: 518
  • PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome

    Kalman Filanovsky, Michal Haran, Vita Mirkin, Andrei Braester, Olga Shevetz, Anfisa Stanevsky, Erica Sigler, Ekaterina Votinov, Yehudit Zalzman-Amir, Alain Berrebi, Atan Gross, Lev Shvidel
    e2020072
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.072
    1316
    PDF: 835
    HTML: 405
  • CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

    Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri
    e2024038
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.038
    2668
    PDF: 1261
    HTML: 130
  • THE IMPACT OF THE SARS-CoV-2 PANDEMIC ON HEALTHCARE PROVISION IN ITALY TO NON-COVID PATIENTS: A SYSTEMATIC REVIEW

    Annarita Botta, Gianmarco Lugli, Matteo Maria Ottaviani, Guido Ascione, Alessandro Bruschi, Federico Cagnazzo, Lorenzo Zammarchi, Paola Romagnani, tommaso portaluri
    e2022012
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.012
    2025
    PDF: 3532
    HTML: 1310
  • How I treat acute and persistent sickle cell pain

    Samir Ballas
    e2020064
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.064
    2107
    PDF: 1175
    HTML: 771
  • MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus

    Emanuele Focà, Silvia Odolini, Nigritella Brianese, Gianpiero Carosi
    e2012032
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.032
    2805
    PDF: 1080
    HTML: 2395
  • Immune thrombocytopenic purpura cases following COVID-19 vaccination.

    Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida
    e2021047
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.047
    1186
    PDF: 487
    HTML: 352
  • Emerging cases of pertussis among early infants born to unvaccinated mothers, an infectious disease long absent in Northwestern Greece

    Alexandros Makis, Vasileios Grammeniatis, Charis Galati, Panagiota Kostara, Evangelia Petridou, Constantina Gartzonika, Athanasios Pappas, Nikolaos Chaliasos
    e2017043
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.043
    2968
    PDF: 703
    HTML: 370
  • PATIENTS WITH ? 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE

    Simone Baldini, Luigi Rigacci, Valentina Carrai, Renato Alterini, Rajmonda Fjerza, Alberto Bosi
    e2012044
    2012-06-28
    https://doi.org/10.4084/mjhid.2012.044
    1292
    PDF: 699
    HTML: 636
  • HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

    Michele Bibas, Gianluigi Biava, Andrea Antinori
    e2011030
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.030
    4619
    PDF: 1549
    HTML: 8546
201 - 250 of 476 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.